NeoGenomics (NEO) Tops Q2 EPS by 6c

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $87 million versus the consensus estimate of $86.55 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Frequency Electronics (FEIM) Tops Q1 EPS by 12c
• Lightpath Technologies (LPTH) Misses Q4 EPS by 5c